Bayer reports €4.5 billion EBITDA before special items, up 9% year-over-year despite currency headwinds. Bayer AG posted first-quarter non-GAAP earnings per share of €2.71 on revenue of €13.41 billion, a 2.4% decline from the same period last year. The company’s EBITDA bef
SIBN reports a smaller-than-expected Q1 loss of $0.1 per share, improving from a $0.15 loss a year ago. Si-Bone posted a first-quarter loss of $0.1 per share, narrower than the Zacks Consensus Estimate of a $0.17 loss. Revenue also exceeded expectations for the period.
Webtoon expects $332M-$342M Q2 revenue Webtoon forecasts Q2 revenue between $332M and $342M. The company aims to return to double-digit growth by year-end. Webtoon is introducing changes to its CANVAS platform, including a unified international platform and an op
CEL-SCI secures $7.2M from a 6M share offering to fund drug development and corporate needs. CEL-SCI priced a public offering of 6M shares at $1.20 each, raising approximately $7.2M in gross proceeds. The funds will support Multikine development, general corporate purposes
The company reported record Q1 2026 revenue and adjusted EBITDA despite a $13 million revenue hit. RadNet raised its 2026 annual recurring revenue (ARR) outlook to over $140M and increased imaging center guidance by $30M. The update follows a strong Q1 2026 performance, wi
ALHC replaces SNCY in S&P SmallCap 600 index Alignment Healthcare will be added to the S&P SmallCap 600 index. The addition is effective prior to the opening of trading on Thursday, May 14. Sun Country Airlines is being removed from the index to make room f
Optex Systems reports Q2 revenue of $9.6M, missing estimates as EPS holds at $0.19 amid a 10.3% year-over-year decline. Optex Systems Holdings posted a Q2 GAAP EPS of $0.19, matching expectations, but revenue of $9.6 million missed estimates by $3.1 million. The company sa
Satellogic reports Q1 GAAP EPS of -$0.84 and $6.11M revenue, both below analyst expectations. Satellogic Inc. reported a first-quarter GAAP loss per share of -$0.84, missing estimates by $0.81. Revenue reached $6.11 million, an 80.2% year-over-year increase but $3.58 milli
AST SpaceMobile reaffirms 2026 revenue guidance of $150M-$200M while targeting 45 operational BlueBird satellites by year-end. AST SpaceMobile announced plans to deploy approximately 45 BlueBird satellites by the end of 2026, reinforcing its revenue guidance of $150M-$200M
HALO forecasts over $1 billion in royalties from ENHANZE partnerships by 2026 and launches a $1 billion share repurchase program. Halozyme Therapeutics expects ENHANZE royalties to exceed $1 billion in 2026, driven by strong partner deal activity and early-stage pipeline p